Full Papers
3-(4-Chlorophenyl)oxazolidin-2-one (1c): 1H NMR (400 MHz,
CDCl3, TMS) d=7.47–7.49 (m, 2H), 7.31–7.34 (m, 2H), 4.46–4.50 (m,
2H), 4.00–4.04 ppm (m, 2H); 13C NMR (100 MHz, CDCl3, TMS) d=
155.2, 137.0, 129.4, 129.2, 119.5, 61.4, 45.2 ppm: HRMS (EI): m/z:
calcd for C9H8ClNO2: 197.0244 [M+]; found 197.0241.
20 mmol), and EO (0.51 mL, 10 mmol) were mixed together and
heated to 1408C for 6 h. After the completion of the reaction,
chloroform (7 mL) was added to the reaction mixture. The organic
phase was washed with water (37 mL) to remove ionic liquid,
and then analyzed by GC with biphenyl as the internal standard.
Product 2a was purified by chromatography on silica gel and char-
acterized structurally by NMR spectroscopy.
3-(3,5-Dichlorophenyl)oxazolidin-2-one (1d): 1H NMR (400 MHz,
CDCl3, TMS) d=7.47 (s, 2H), 7.10 (s, 1H), 4.49 (t, J=8.0 Hz, 2H),
4.01 ppm (t, J=8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3, TMS) d=
154.7, 140.2, 135.5, 123.9, 116.3, 61.4, 45.0 ppm; HRMS (EI): m/z:
calcd for C9H7Cl2NO2: 230.9854 [M+]; found 230.9855.
[1,3]Dithiolan-2-ylidenephenylamine (2a): 1H NMR (400 MHz,
CDCl3, TMS) d=7.33 (t, J=7.8 Hz, 2H), 7.11 (t, J=7.4 Hz, 1H), 6.96
(d, J=6.4 Hz, 2H), 3.47–3.56 ppm (m, 4H); 13C NMR (100 MHz,
CDCl3, TMS) d=171.4, 152.3, 129.0, 124.5, 120.1, 37.9, 35.1 ppm;
HRMS (EI): m/z: calcd for C9H9NS2 195.0176 [M+]; found 195.0173.
3-(4-Ethoxyphenyl)oxazolidin-2-one (1e): 1H NMR (400 MHz,
CDCl3, TMS) d=7.40–7.42 (m, 2H), 6.88–6.90 (m, 2H), 4.42–4.46 (m,
2H), 3.98–4.04 (m, 4H), 1.40 ppm (t, J=7.0 Hz, 3H); 13C NMR
(100 MHz, CDCl3, TMS) d=155.9, 155.7, 131.4, 120.4, 115.0, 63.8,
61.4, 45.8, 14.9 ppm; HRMS (EI): m/z: calcd for C11H13NO3: 207.0895
[M+]; found 207.0892.
Acknowledgements
We thank the National Natural Science Foundation of China
(grant number 21273078, 21473056, 21573072), Shanghai Natu-
ral Science Foundation (14ZR1411800) and Shanghai Leading
Academic Discipline Project (project number B409) for financial
support.
3-(4-Methoxyphenyl)oxazolidin-2-one (1 f): 1H NMR (400 MHz,
CDCl3, TMS) d=7.43 (d, J=9.2 Hz, 2H), 6.91 (d, J=9.2 Hz, 2H), 4.46
(t, J=8.0 Hz, 2H), 4.01 (t, J=8.0 Hz, 2H), 3.78 ppm (s, 3H); 13C NMR
(100 MHz, CDCl3, TMS) d=156.5, 155.7, 131.6, 120.4, 114.4, 61.4,
55.6, 45.8 ppm; HRMS (EI): m/z: calcd for C10H11NO3: 193.0739 [M+];
found 193.0741.
1
3-p-Tolyloxazolidin-2-one (1g): H NMR (400 MHz, CDCl3, TMS) d=
Keywords: carbon dioxide fixation · cooperative effects ·
7.39 (d, J=8.4 Hz, 2H), 7.16 (d, J=8.4 Hz, 2H), 4.40- 4.44 (m, 2H),
3.96–4.00 (m, 2H), 2.31 ppm (s, 3H); 13C NMR (100 MHz, CDCl3,
TMS) d=155.4, 135.8, 133.7, 129.6, 118.4, 61.3, 45.3, 20.8 ppm:
HRMS (EI): m/z: calcd for C10H11NO2: 177.0790 [M+]; found
177.0791.
density functional calculations
mechanisms
· ionic liquids · reaction
[1] K. Sumida, D. L. Rogow, J. A. Mason, T. M. McDonald, E. D. Bloch, Z. R.
[4] T. Ema, Y. Miyazaki, J. Shimonishi, C. Maeda, J.-y. Hasegawa, J. Am.
[5] J. Sun, W. Cheng, Z. Yang, J. Wang, T. Xu, J. Xin, S. Zhang, Green Chem.
1
3-Naphthalen-1-yloxazolidin-2-one (1h): H NMR (400 MHz, CDCl3,
TMS) d=7.81–7.88 (m, 3H), 7.42–7.55 (m, 4H), 4.53–4.57 (m, 2H),
3.98–4.02 ppm (m, 2H); 13C NMR (100 MHz, CDCl3, TMS) d=157.5,
134.6, 134.1, 129.9, 128.7, 128.6, 127.0, 126.5, 125.7, 124.6, 122.4,
62.6, 49.1 ppm; HRMS (EI): m/z: calcd for C13H11NO2: 213.0790 [M+];
found 213.0793.
1
3-Cyclohexyloxazolidin-2-one (1i): H NMR (400 MHz, CDCl3, TMS)
d=4.27–4.31 (m, 2H), 3.62–3.69 (m, 1H), 3.48–3.52 (m, 2H), 1.78–
1.79 (m, 4H), 1.64–1.67 (m, 1H), 1.33–1.35 (m, 4H), 1.05–1.10 ppm
(m, 1H); 13C NMR (100 MHz, CDCl3, TMS) d=157.9, 62.1, 52.6, 40.7,
30.4, 25.5, 25.4 ppm; HRMS (EI): m/z: calcd for C9H15NO2: 169.1103
[M+]; found 169.1100.
1
5-Methyl-3-phenyloxazolidin-2-one (1j): H NMR (500 MHz, CDCl3,
TMS) d=7.52 (d, J=8.0 Hz, 2H), 7.36 (t, J=8.0 Hz, 2H), 7.12 (t, J=
7.3 Hz, 1H), 4.76–4.78 (m, 1H), 4.11 (t, J=8.3 Hz, 1H), 3.60–3.63 (m,
1H), 1.52 ppm (d, J=6.0 Hz, 3H); 13C NMR (125 MHz, CDCl3, TMS)
d=154.9, 138.4, 129.1, 124.0, 118.2, 69.6, 51.9, 20.7 ppm; HRMS
(EI): m/z: calcd for C10H11NO2: 177.0790 [M+]; found 177.0789.
[10] a) R. Qiu, Z. Meng, S. Yin, X. Song, N. Tan, Y. Zhou, K. Yu, X. Xu, S. Luo,
6843; c) Y. Xie, T.-T. Wang, X.-H. Liu, K. Zou, W.-Q. Deng, Nat. Commun.
2013, 4, 1960–1966; d) X.-B. Lu, B. Liang, Y.-J. Zhang, Y.-Z. Tian, Y.-M.
3-(4-Bromophenyl)-5-methyloxazolidin-2-one
(1k):
1H NMR
(400 MHz, CDCl3, TMS) d=7.39–7.46 (m, 4H), 4.73–4.82 (m, 1H),
4.06 (t, J=8.4 Hz, 1H), 3.55–3.59 (m, 4H), 1.52 ppm (d, J=6.4 Hz,
3H); 13C NMR (100 MHz, CDCl3, TMS) d=154.7, 137.6, 132.0, 119.7,
116.8, 69.7, 51.8, 20.8 ppm; HRMS (EI): m/z: calcd for C10H10BrNO2:
254.9895 [M+]; found 254.9897.
[12] J. Tharun, G. Mathai, A. C. Kathalikkattil, R. Roshan, J.-Y. Kwak, D.-W.
Typical procedure for the conversion of CS2 to 2a catalyzed
by DBU and HDBUBr
The reaction was performed in a 15 mL closed pressure bottle
equipped with a magnetic stirrer. DBU (0.046 g, 0.3 mmol), HDBUBr
(0.023 g, 0.1 mmol), aniline (0.093 g, 1.0 mmol), CS2 (1.21 mL,
ChemCatChem 2016, 8, 830 – 838
837
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim